Conditions: Myeloproliferative Neoplasm; Primary Myelofibrosis; Essential Thrombocythemia; Polycythemia Vera
Intervention: Drug: Mirabegron
Sponsor: Swiss Group for Clinical Cancer Research
Not yet recruiting – verified December 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days